Therefore, we examined the status of NF-κB activity in isoflavone genistein treated breast, prostate, lung, and pancreatic cancer cells by electrophoresis mobility shift assay (EMSA) during our earlier studies [91,92,93,95,97]. Here, NFKB1 is linked to pancreatic neoplasm.